Pregnant patients with coccidioidomycosis develop dissemination and serious disease more frequently than do the general population. To assist in prognosis and management, we analyzed the significance of erythema nodosum in pregnant patients with coccidioidomycosis. Sixty-one pregnant patients (mean age { SD, 26.4 { 6.3 years) were evaluated. Seventy percent of the patients were Hispanic; 15%, African American; 13%, Caucasian; and 2%, unknown race. Of the 30 patients (49%) who developed erythema nodosum, 0 had disseminated disease (P Å .001), 1 (3%) with pulmonary involvement required therapy for ú1 year, and 29 (97%) recovered (P Å .0008). Of the 31 patients (51%) without erythema nodosum, 11 (35%) had disseminated disease, 12 (39%) required therapy for ú1 year, 17 (55%) recovered, 1 (3%) died, and 1 (3%) had an outcome that was unknown. Erythema nodosum appears to be a salient marker of a positive outcome for pregnant patients, more so than for the general population.
Coccidioidomycosis during pregnancy is a serious illness for infection in this period can be affected by pregnancy, and in many individuals the timing of primary infection is inexact. which high rates of mortality have been reported in many studies [1 -7] . It has been associated with a greater likelihood
Patients who gave birth to live infants and stillborn infants and patients who had an abortion were included in the study. of extrapulmonary dissemination and serious disease [1, 3, 4, 7, 8] , in addition to untoward effects on fetuses [1, 3, 4, 6, 9 - Thirty-one patients were identified in 1993 during the peak of the coccidioidomycosis epidemic in Kern County, . Erythema nodosum is generally a self-limited inflammatory disorder of the skin and subcutaneous tissues that is characnia. Data for 29 patients identified in 1993 were collected by cross-referencing the Kern County Health Department's birth terized by multiple painful nodules usually limited to the extremities. In areas of endemicity, primary infection with records with their coccidioidomycosis serology records. Twenty-five patients with positive serology were excluded Coccidioides immitis represents up to 95% of cases of erythema nodosum [12] . After the initial description of an association from the study because they were asymptomatic and we were unable to assess the date of exposure to C. immitis. These between erythema nodosum and coccidioidomycosis, the relatively benign nature of coccidioidomycosis in patients with patients were identified at the Kern Medical Center Obstetrics Clinic, which performs skin testing of all pregnant women erythema nodosum was noted [13 -16] . The significance of erythema nodosum in pregnancy is uncertain. In this study, we for coccidioidomycosis and performs serology if a skin test is positive. The ethnicity at the study institution was as follows: report the frequency of erythema nodosum in pregnant patients with coccidioidomycosis and describe the significance of this Hispanic, 47% of all patients; Caucasian, 44%; African American, 6%; Asian and other, 3%. Erythema nodosum was characfinding in relationship to outcome.
terized as painful nodular lesions affecting predominately or solely the lower extremities. The diagnosis of erythema nodoMethods sum was clinical, and pathological specimens were not obtained. We retrospectively identified 86 pregnant patients with evidence of coccidioidomycosis from 1987 to 1994. Patients inSixty-one patients were included in the study; the mean age { SD of the patients was 26.4 { 6.3 years. The ethnicity of cluded in the study had symptomatic illness typical of acute coccidioidomycosis and either positive serology for any IgM the patients was as follows: Hispanic, 70%; African American, 15%; Caucasian, 13%; and unknown, 2%. The demographics antibody (detected by immunodiffusion) or CF (complement fixation) antibodies (titer, §1:4). Illness had to occur 3 months and clinical characteristics of the patients were described, and the outcomes for patients with and without erythema nodosum before or after pregnancy. This time frame was chosen because were compared. Outcomes were grouped as recovery from infection, chronic illness (serious pulmonary disease requiring treatment for §1 year), or death. titers of CF antibody and negative skin tests was noted for these patients. The outcome for pregnant patients without erythema nodosum appears to be less favorable, although over one-half of these patients recovered. Only one patient without erythema for Disease Control and Prevention, Atlanta). For comparison, nodosum died. outcomes were dichotomized as recovered or not recovered.
The demographics of this study were skewed toward Hispanics and African Americans, primarily because of the demographics of Kern County, the population of the study institution Results (a 270-bed public hospital in Bakersfield, CA), and the fertility Of 61 pregnant patients with coccidioidomycosis, 30 (49%) rates among different populations. However, Caucasians were developed erythema nodosum and 31 patients (51%) did not represented in both groups, and Hispanics and African Ameridevelop erythema nodosum. No patients were known to be cans have a predisposition to serious disease. Despite this skew, immunocompromised. The demographics of the patients are we believe that this study provides useful data for the manageshown in table 1. The trimester of onset was similar in both ment of coccidioidomycosis during pregnancy, especially since groups. Three patients (5%) developed coccidioidomycosis the commonly used therapeutic agents in the management of within 3 months before their pregnancy; 14 (23%), in the first this disease have teratogenic effects [19] . trimester; 14 (23%), in the second trimester; 26 (42%), in the Given the outcome differences found between these two third trimester; and 4 (7%), within 3 months after birth.
groups and the difficult treatment decisions for pregnant paThe clinical characteristics of the patients are shown in table tients with coccidioidomycosis, we believe that the presence 2. The median titer of CF antibody for patients with erythema of erythema nodosum is an important factor in decision making. nodosum was 1:8 (range, 1:1 to 1:128), and the median titer This study shows that erythema nodosum is a salient marker of CF antibody for patients without erythema nodosum was 1:16 (range, 1:1 to 1:1,024). Skin tests were performed for of those patients without erythema nodosum (P Å .0008).
NOTE. Unless stated otherwise, data are no. (%) of patients with indicated characteristic.
Discussion
* Results are no. of patients with negative spherulin skin tests/total no. who underwent spherulin skin tests (%).
Coccidioidomycosis during pregnancy is a serious condition † For comparison, outcomes were dichotomized as recovered or not recovered.
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